Evidence map›Paper›PMID 24967222›Full record

ReviewFrontiers in chemistry2014

Genus Cistus: a model for exploring labdane-type diterpenes' biosynthesis and a natural source of high value products with biological, aromatic, and pharmacological properties.

Dimitra Papaefthimiou, Antigoni Papanikolaou, Vasiliki Falara, Stella Givanoudi, Stefanos Kostas, Angelos K Kanellis

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Sequential soxhlet fractionation ofFrontiers in chemistry · 2026
    Article
  3. Article
  4. Molecules (Basel, Switzerland) · 2025
    Review
  5. Biology, Antioxidant Activity, and Therapeutic Potential ofInternational journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Labdanum Resin fromMolecules (Basel, Switzerland) · 2024
    Article
  13. Efficacy of Two MoroccanMolecules (Basel, Switzerland) · 2023
    Article
  14. Polyphenol Profile ofAntioxidants (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Phytochemistry and Antihyperglycemic Potential ofMolecules (Basel, Switzerland) · 2022
    Article
  18. Article
  19. Insight intoPhysiology and molecular biology of plants : an international journal of functional plant biology · 2022
    Article
  20. Antioxidant and Antiglycation Effects ofMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Dimitra PapaefthimiouGroup of Biotechnology of Pharmaceutical Plants, Laboratory of Pharmacognosy, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki Thessaloniki, Greece.
Antigoni PapanikolaouGroup of Biotechnology of Pharmaceutical Plants, Laboratory of Pharmacognosy, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki Thessaloniki, Greece.
Vasiliki FalaraDepartment of Chemical Engineering, Delaware Biotechnology Institute, University of Delaware Newark, DE, USA.
Stella GivanoudiGroup of Biotechnology of Pharmaceutical Plants, Laboratory of Pharmacognosy, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki Thessaloniki, Greece.
Stefanos KostasDepartment of Floriculture, School of Agriculture, Aristotle University of Thessaloniki Thessaloniki, Greece.
Angelos K KanellisGroup of Biotechnology of Pharmaceutical Plants, Laboratory of Pharmacognosy, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRBiotechnology Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The family Cistaceae (Angiosperm, Malvales) consists of 8 genera and 180 species, with 5 genera native to the Mediterranean area (Cistus, Fumara, Halimium, Helianthemum, and Tuberaria). Traditionally, a number of Cistus species have been used in Mediterranean folk medicine as herbal tea infusions for healing digestive problems and colds, as extracts for the treatment of diseases, and as fragrances. The resin, ladano, secreted by the glandular trichomes of certain Cistus species contains a number of phytochemicals with antioxidant, antibacterial, antifungal, and anticancer properties. Furthermore, total leaf aqueous extracts possess anti-influenza virus activity. All these properties have been attributed to phytochemicals such as terpenoids, including diterpenes, labdane-type diterpenes and clerodanes, phenylpropanoids, including flavonoids and ellagitannins, several groups of alkaloids and other types of secondary metabolites. In the past 20 years, research on Cistus involved chemical, biological and phylogenetic analyses but recent investigations have involved genomic and molecular approaches. Our lab is exploring the biosynthetic machinery that generates terpenoids and phenylpropanoids, with a goal to harness their numerous properties that have applications in the pharmaceutical, chemical and aromatic industries. This review focuses on the systematics, botanical characteristics, geographic distribution, chemical analyses, biological function and biosynthesis of major compounds, as well as genomic analyses and biotechnological approaches of the main Cistus species found in the Mediterranean basin, namely C. albidus, C. creticus, C. crispus, C. parviflorus, C. monspeliensis, C. populifolius, C. salviifolius, C. ladanifer, C. laurifolius, and C. clusii.

Indexed as

biological actionbiosynthesisCistusgenomic approacheslabdane-type diterpenesphenylpropanoids

Identifiers

PMID24967222
PMCPMC4052220
OpenAlexW2145869012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.